Pharmapack
January 24-25, 2024 Paris, France https://www.pharmapackeurope.com/
read moreSubscribe to our press distribution list to receive the latest news about AMW.
No events available
January 24-25, 2024 Paris, France https://www.pharmapackeurope.com/
read moreFebruary 08-09, 2024
London, UK
February 26-27, 2024 Lisbon, Portugal
read moreMarch 18-20, 2024
Barcelona, Spain
https://informaconnect.com/bioeurope-spring/
March 19-21, 2024
Boston, MA
https://wet-amd-drug-development.com/
June 03-06, 2024
San Diego, California
https://www.bio.org/events/bio-international-convention
July 10-12, 2024 Bangkok, Thailand https://www.cphi.com/sea/en/home.html
read moreOctober 08-10, 2024 Milan, Italy https://www.cphi.com/europe/en/home.html
read moreOctober 28-29, 2024 Boston, USA https://poddconference.com
read moreNovember 04-06, 2024 Stockholm, Sweden https://informaconnect.com/bioeurope/
read moreWarngau, Germany, November 28, 2023 AMW GmbH, a specialty pharmaceutical company focused on innovative sustained-release drug delivery systems, today announced the expansion of its leadership team to implement its strategic growth strategy. Following Philipp Karbach taking over the role of Chief Executive Officer (CEO) in June this year, Sebastian Herzog now strengthens the management team […]
read moreWarngau, November 28, 2023 AMW GmbH, a pharmaceutical company specializing in innovative drug delivery systems, today announced the expansion of its management team to implement its strategic growth strategy. After taking over the role of Chief Executive Officer (CEO) from Philipp Karbach in June of this year, Sebastian Herzog is strengthening the management team with […]
read moreAMW GmbH, a specialty pharmaceutical company focused on innovative sustained-release drug delivery systems, today announced that it has achieved a key milestone in opening new markets within the European Union (EU) and beyond with the final report of the first Notified Body Opinion (NBO) for its goserelin implant.
read moreAMW GmbH, a pharmaceutical company specializing in innovative drug delivery systems, today released its financial results for the year ended December 31, 2022. AMW reported record consolidated sales for 2022 of €22.8 million and achieved operating profitability for the first time in the company’s history. The company also reported that Philipp Karbach will assume the position of chief executive officer (CEO) effective June 1, 2023, as Dr. Konstantin Petropoulos has decided to step down as CEO of AMW GmbH effective May 31, 2023, to pursue new opportunities. Philipp Karbach joined AMW in 2016, most recently in his role as Chief Operating Officer (COO) and Chief Financial Officer (CFO).
read moreAMW GmbH, a pharmaceutical company specializing in innovative drug delivery systems, today announced the appointment of Prof. Dr. Olivia Merkel, Professor of Drug Delivery at the Faculty of Chemistry and Pharmacy of Ludwig-Maximilians-Universität (LMU) Munich, as a member of its Scientific Advisory Board (SAB). Prof. Merkel is an internationally recognized expert in novel and targeted drug delivery systems, including RNA delivery systems. Her appointment will strengthen AMW’s scientific expertise in sustained-release delivery systems, such as biodegradable implants, and contribute to the company’s strategic development plans. With her appointment, Prof. Merkel succeeds Prof. Dr. Gerhard Winter, who will step down from his position on the Scientific Advisory Board.
read more